Allergan Plc (AGN) 305.98 $AGN Allergan, Valeant Seek

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allergan Plc (AGN) 305.98 $AGN

Allergan, Valeant Seek Support, Reset Base Counts
at Investor's Business Daily - Wed Aug 26, 4:56PM CDT
Only three IBD 50 stocks are headquartered outside the U.S. That is an unusually small number of overseas representatives on the list. A month ago, the IBD 50 included six foreign names. In late January, there were eight. Two of the three current...
AGN: 305.98 (+15.35), VRX: 227.24 (+7.16), ICLR: 78.95 (+3.28)

Eli Lilly's Alimta Patent Upheld by U.S. District Court
Zacks Equity Research - Zacks Investment Research - Wed Aug 26, 3:35PM CDT
Eli Lilly and Company announced that it has received a favorable ruling in a lawsuit related to the infringement of vitamin regimen patent for Alimta.
AGN: 305.98 (+15.35), GILD: 106.96 (+4.40), TEVA: 64.82 (+0.61), LLY: 81.10 (+2.84)

Acorda (ACOR) Gets Favorable Outcome in Ampyra IPR Issue
Zacks Equity Research - Zacks Investment Research - Tue Aug 25, 3:40PM CDT
Acorda (ACOR) received encouraging news with the patent review board refusing to review two patents related to Ampyra.
AGN: 305.98 (+15.35), BIIB: 298.25 (+16.51), TEVA: 64.82 (+0.61), ACOR: 31.96 (+0.59)

Gilead Leads 4 Drugmakers In Top Sector Performers
at Investor's Business Daily - Tue Aug 25, 2:06PM CDT
Following a three-day plummet, stocks popped Tuesday, with several top drugmakers like Gilead making a climb. Today's Screen of the Day focuses on Top Sector Performers. Over half of a stock's price move can be attributed to the strength of its...
AGN: 305.98 (+15.35), VRX: 227.24 (+7.16), GILD: 106.96 (+4.40), SCMP: 24.55 (+0.61), TEVA: 64.82 (+0.61)

10 Stocks George Soros is Buying in 2015
at The Street - Tue Aug 25, 5:57AM CDT
Here's a closer look at 10 stocks that Soros Fund Management bought in the most recently reported quarter.
ENDP: 76.38 (+3.29), SSNC: 66.51 (+1.39), ALLY: 21.08 (+0.29), DAL: 43.70 (+2.33), C: 52.28 (+2.40), CHTR: 177.60 (+6.31), YPF: 19.75 (+0.73), ESGR: 146.94 (+0.98), LUV: 37.39 (+0.87), ZTS: 44.25 (+1.69), AGN: 305.98 (+15.35), AA: 8.26 (+0.15), RLGY: 40.55 (+1.38), AAL: 38.85 (+1.35), ETFC: 25.26 (+1.12), TEVA: 64.82 (+0.61), TWC: 185.20 (+4.48), PCRX: 57.95 (+1.00), NRG: 19.07 (+0.17), SCHW: 29.74 (+0.94)

Allergan and Gedeon Richter Plc. to Present Data from Cariprazine trials at European College of Neuropsychopharmacology (ECNP) Annual Meeting in Amsterdam
PR Newswire - Tue Aug 25, 1:00AM CDT
Allergan plc (NYSE: AGN) and Gedeon Richter Plc today announced they will present data on the investigational drug cariprazine in patients with schizophrenia and acute mania in bipolar I disorder during the 28th European College of Neuropsychopharmacology (ECNP) annual congress in Amsterdam, to be held August 29 - September 1, 2015.
AGN: 305.98 (+15.35)

Markets Fall In China & Japan, U.S. Indices Could Follow – Markets This Morning
Dana Blankenhorn - Amigobulls - Tue Aug 25, 12:00AM CDT
A 7.6% fall in the Shanghai Composite and a 4% decline in the Nikkei signal more weakness for U.S. markets this morning. Oil prices will be of interest too.
AGN: 305.98 (+15.35), NFLX: 110.13 (+8.61), PXD: 108.86 (+1.62), FB: 87.19 (+4.19), EOG: 70.99 (+2.63), XOM: 72.50 (+3.79), AAPL: 109.69 (+5.95), REGN: 535.47 (+36.45), CELG: 119.23 (+6.53)

Look for Shares of Allergan to Potentially Rebound after Yesterday's 2.26% Sell Off
Comtex SmarTrend(R) - Mon Aug 24, 5:01PM CDT
Allergan (NYSE:AGN) traded in a range yesterday that spanned from a low of $277.83 to a high of $307.26. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $292.04 on volume of 5.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AGN: 305.98 (+15.35)

10 Stocks Billionaire John Paulson Is Buying in 2015
at The Street - Mon Aug 24, 11:07AM CDT
Here's a closer look at 10 stocks Paulson & Co. bought in the most recently reported quarter.
WWAV: 44.86 (+2.76), SGYP: 7.05 (+0.61), AGN: 305.98 (+15.35), PMC: 33.10 (+1.15), VRX: 227.24 (+7.16), BRCM: 49.85 (+2.66), SHPG: 223.81 (+4.35), MYL: 51.13 (+2.02), TEVA: 64.82 (+0.61), SYMX: 0.82 (+0.01), HOT: 71.09 (+1.47)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 19

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 24

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 11

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 24

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 15

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 27

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Huawei eKit Unveils Over 30 Innovative Products to Boost Partners

Updated Category News Views 169

Huawei eKit Launches New Innovative Solutions In a groundbreaking event, Huawei showcased its commitment to supporting the growth of its partners in the distribution business. The recent forum revealed an impressive array of over 30 new products designed to enhance the competitiveness of Huawei eKit and facilitate the digital transformation journeys of small and medium...

Continue Reading
EDAP TMS Strengthens Board with Joshua H. Levine's Appointment

Updated Category News Views 161

EDAP TMS Welcomes Joshua H. Levine to Board of Directors EDAP TMS SA (Nasdaq: EDAP), a recognized leader in robotic energy-based therapies, has made a significant addition to its Board of Directors with the appointment of Joshua H. Levine. This strategic move marks a pivotal moment for the company as it continues to strengthen its position within the medical technology...

Continue Reading
Salama's Impressive H1 2025 Growth Highlights Financial Stability

Updated Category News Views 233

Salama's Remarkable Financial Growth in H1 2025 Salama (DFM: "SALAMA"), one of the leading Takaful providers in the region, has recently announced substantial financial results for the first half of 2025. The company reported a net profit of AED 8.25 million, demonstrating its commitment to operational excellence and sustainability. Profitability Driven by Strong Q2...

Continue Reading
Navigating the Rise of Intraoral Scanners in Modern Dentistry

Updated Category News Views 353

Understanding the Growth of Intraoral Scanners The global intraoral scanners market is experiencing a remarkable transformation, projecting a leap from US$ 786.5 million in 2024 to a staggering US$ 1,798.8 million by 2033. This growth signals a compound annual growth rate (CAGR) of 9.6% between 2025 and 2033, indicating a significant shift towards digital solutions in...

Continue Reading
Revolutionizing Risk Management: Oscilar's Innovative AI Agents

Updated Category News Views 129

Revolutionizing Risk Management with AI Oscilar Launches Revolutionary Agentic AI Platform Transforming Risk Decisioning Oscilar, the leading innovator in AI-driven risk management, has announced the launch of its groundbreaking AI Agent platform, reshaping how organizations manage online risk. Built around a network of specialized AI agents, Oscilar's platform addresses...

Continue Reading